
Please try another search
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Qing Yang | 52 | 2017 | Co-CEO & Executive Director |
Minzhang Chen | 53 | 2015 | Co-CEO & Executive Director |
Ge Li | 58 | 2000 | Co-Founder, Executive Chairman, President & CEO |
Shaohua Lu-Wong | 56 | 2007 | Independent Non-Executive Director |
Zhaohui Zhang | 56 | 2002 | COO of China, Executive VP & Executive Director |
Zhu Minfang | 54 | 2017 | Employee Representative Supervisor |
Wu Baiyang | 62 | 2020 | Supervisor |
Zhiling Zhan | 62 | 2023 | Independent Non-Executive Director |
Xiaomeng Tong | 51 | 2017 | - |
Wei Yu | 72 | 2023 | Independent Non-Executive Director |
Xuesong Leng | 55 | 2024 | Independent Non-Executive Director |
Wu Yibing | 58 | 2017 | Non-Executive Director |
Xiaomeng Tong | 52 | 2017 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review